Phase II study of cystemustine in advanced head and neck cancer. A trial of the EORTC Clinical Screening Group

Eur J Cancer B Oral Oncol. 1995 Mar;31B(2):151-2. doi: 10.1016/0964-1955(94)00047-8.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase II
  • Letter

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Squamous Cell / drug therapy*
  • Head and Neck Neoplasms / drug therapy*
  • Humans
  • Male
  • Middle Aged
  • Nitrosourea Compounds / therapeutic use*

Substances

  • Antineoplastic Agents
  • Nitrosourea Compounds
  • N'-(2-chloroethyl)-N-(2-(methylsulfonyl)ethyl)-N'-nitrosourea